Combining Avutometinib With Defactinib Yields High Response Rates in LGSOC.

Subjects

Subjects :

MITOGEN-activated protein kinases
MEETINGS
OVARIAN tumors
RARE diseases
TUMOR grading
DISEASE remission
CANCER chemotherapy
TRANSFERASES
GENETIC mutation
PROGRESSION-free survival
OVERALL survival

Details

Language :

English

ISSN :

15398226

Volume :

13

Issue :

6

Database :

Complementary Index

Journal :

Targeted Therapies in Oncology

Publication Type :

Periodical

Accession number :

177144906